EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic Solid Organ Transplant Recipients: A Systematic Review and Meta‐Analysis of Comparative Studies

Min Jung Geum iD, Kyung Sun Oh iD, Young-Mi Ah iD

Journal of Diabetes Research · 2026-01 · 2026 (1)

DOI: 10.1155/jdr/8540354 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Diabetes Research, online erschienen am 19.01.2026. Verfasst von Min Jung Geum und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea, yuhs.or.kr. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Organ Transplantation, Transplant Recipients, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yeungnam University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Solid organ transplant recipients with diabetes mellitus face unique challenges in glycemic control, compounded by the metabolic effects of immunosuppressants. Although sodium–glucose cotransporter 2 (SGLT2) inhibitors are effective in diabetes, evidence for their use in transplant recipients remains limited. We aimed to systematically review the efficacy and safety of SGLT2 inhibitors in transplant recipients with diabetes.

Methods

A systematic review and meta‐analysis was conducted by searching the MEDLINE, Embase, and Cochrane CENTRAL databases for studies published before July 2025. Seventeen comparative studies involving 12,892 transplant recipients with diabetes were included. Efficacy and safety data of SGLT2 inhibitors were extracted and analyzed. A random‐effects model was used to pool the results.

Results

SGLT2 inhibitors led to a significantly greater reduction in HbA1c (mean difference [MD]: −0.59% and 95% confidence interval [CI]: −0.91 to −0.26) and body mass index (MD: −0.82 kg/m 2 and 95% CI: −1.54 to −0.10) compared to controls. The risks of dialysis (odds ratio [OR]: 0.50 and 95% CI: 0.31–0.79), major adverse cardiovascular events (OR: 0.29 and 95% CI: 0.22–0.38), heart failure (OR: 0.66 and 95% CI: 0.52–0.83), urinary tract infection (OR: 0.45 and 95% CI: 0.22–0.92), graft rejection (OR: 0.73, 95% and CI: 0.64–0.83), and all‐cause mortality (OR: 0.40 and 95% CI: 0.27–0.59) were significantly lower in the SGLT2 inhibitor group.

Conclusions

SGLT2 inhibitors were associated with improved glycemic control, weight reduction, and favorable trends in cardiovascular outcomes among solid organ transplant recipients. Most safety outcomes, including urinary tract infection and graft rejection, were comparable between groups or more favorable in the SGLT2 inhibitor group, particularly among kidney transplant recipients. These findings support the use of SGLT2 inhibitors in this population. However, further large‐scale studies are warranted to validate these results and assess the long‐term effects across different transplant types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsOrgan TransplantationTransplant RecipientsDiabetes Mellitus, Type 2Diabetes MellitusHumansGlycated HemoglobinBlood GlucoseTreatment Outcome

Substanzen

Sodium-Glucose Transporter 2 InhibitorsGlycated HemoglobinBlood Glucose

Autor:innen und Institutionen

  • Department of Pharmacy, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea, yuhs.or.kr.
  • College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea, yu.ac.kr.

ORCID-Profile: Min Jung Geum, Kyung Sun Oh, Young-Mi Ah

Förderung

  • Yeungnam University

Zitieren

APA

Geum, M. J., Oh, K. S., & Ah, Y. M. (2026). Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic Solid Organ Transplant Recipients: A Systematic Review and Meta‐Analysis of Comparative Studies. Journal of Diabetes Research, 2026(1). https://doi.org/10.1155/jdr/8540354

Vancouver

Geum MJ, Oh KS, Ah YM. Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic Solid Organ Transplant Recipients: A Systematic Review and Meta‐Analysis of Comparative Studies. Journal of Diabetes Research. 2026;2026(1). doi:10.1155/jdr/8540354

BibTeX
@article{Geum2026,
  author = {Geum, Min Jung and Oh, Kyung Sun and Ah, Young-Mi},
  title = {Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic Solid Organ Transplant Recipients: A Systematic Review and Meta‐Analysis of Comparative Studies},
  journal = {Journal of Diabetes Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jdr/8540354}
}
Kostenlos starten →